Search research articles
Contact Us
Filters
Showing results (251-260 of 300) with videos related to
Page
of 30
Sort By:
Breast Cancer Research and Treatment
|
October 15, 2013
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
Anja Welt, Mitra Tewes, Bahriye Aktas, et al.
Oncology Research and Treatment
|
January 31, 2023
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
Julius Roehrle, Stefan Kasper, Jürgen-Walter Treckmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2026
Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma
Elena Garralda, Patrick Schöffski, Arjun Oberoi, et al.
The New England Journal of Medicine
|
March 28, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancer
Alice T Shaw, Dong-Wan Kim, Ranee Mehra, et al.
Translational Lung Cancer Research
|
July 17, 2025
The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis
Andreas Herz, Maja Guberina, Christoph Pöttgen, et al.
Journal of Cancer Research and Clinical Oncology
|
December 22, 2015
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jens Köhler, Martin Schuler, Thomas Christoph Gauler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
The New England Journal of Medicine
|
August 20, 2015
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M Hyman, Igor Puzanov, Vivek Subbiah, et al.
The New England Journal of Medicine
|
June 7, 2021
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
Ferdinandos Skoulidis, Bob T Li, Grace K Dy, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 300) with videos related to
Sort By:
Page
of 30
Breast Cancer Research and Treatment
|
October 15, 2013
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
Anja Welt, Mitra Tewes, Bahriye Aktas, et al.
Oncology Research and Treatment
|
January 31, 2023
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
Julius Roehrle, Stefan Kasper, Jürgen-Walter Treckmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2026
Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma
Elena Garralda, Patrick Schöffski, Arjun Oberoi, et al.
The New England Journal of Medicine
|
March 28, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancer
Alice T Shaw, Dong-Wan Kim, Ranee Mehra, et al.
Translational Lung Cancer Research
|
July 17, 2025
The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis
Andreas Herz, Maja Guberina, Christoph Pöttgen, et al.
Journal of Cancer Research and Clinical Oncology
|
December 22, 2015
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jens Köhler, Martin Schuler, Thomas Christoph Gauler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
The New England Journal of Medicine
|
August 20, 2015
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M Hyman, Igor Puzanov, Vivek Subbiah, et al.
The New England Journal of Medicine
|
June 7, 2021
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
Ferdinandos Skoulidis, Bob T Li, Grace K Dy, et al.
Page
of 30